Search research articles
Contact Us
Filters
Showing results (11-20 of 230) with videos related to
Page
of 23
Sort By:
Current Cardiology Reports
|
September 4, 2012
Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes
Niina Matikainen, Marja-Riitta Taskinen
Handbook of Experimental Pharmacology
|
October 22, 2021
Metabolism of Triglyceride-Rich Lipoproteins
Jan Borén, Marja-Riitta Taskinen
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 9, 2010
CVD in women
Barbara V Howard, Marja-Riitta Taskinen
Current Diabetes Reports
|
March 28, 2008
Fatty liver, insulin resistance, and dyslipidemia
Martin Adiels, Marja-Riitta Taskinen, Jan Borén
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
December 28, 2018
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Soo Lim, Marja-Riitta Taskinen, Jan Borén
Primary Care Diabetes
|
February 23, 2010
Reviewing statin therapy in diabetes--towards the best practise
Niina Matikainen, Juhani Kahri, Marja-Riitta Taskinen
Nutrients
|
August 25, 2019
Dietary Fructose and the Metabolic Syndrome
Marja-Riitta Taskinen, Chris J Packard, Jan Borén
Frontiers in Endocrinology
|
June 2, 2020
Causes and Consequences of Hypertriglyceridemia
Chris J Packard, Jan Boren, Marja-Riitta Taskinen
Annual Review of Nutrition
|
April 18, 2024
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja-Riitta Taskinen, Chris J Packard
Frontiers in Endocrinology
|
August 28, 2020
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Borén, Chris J Packard, Marja-Riitta Taskinen
Page
of 23
Search research articles
Search
Showing results (11-20 of 230) with videos related to
Sort By:
Page
of 23
Current Cardiology Reports
|
September 4, 2012
Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes
Niina Matikainen, Marja-Riitta Taskinen
Handbook of Experimental Pharmacology
|
October 22, 2021
Metabolism of Triglyceride-Rich Lipoproteins
Jan Borén, Marja-Riitta Taskinen
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 9, 2010
CVD in women
Barbara V Howard, Marja-Riitta Taskinen
Current Diabetes Reports
|
March 28, 2008
Fatty liver, insulin resistance, and dyslipidemia
Martin Adiels, Marja-Riitta Taskinen, Jan Borén
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
December 28, 2018
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Soo Lim, Marja-Riitta Taskinen, Jan Borén
Primary Care Diabetes
|
February 23, 2010
Reviewing statin therapy in diabetes--towards the best practise
Niina Matikainen, Juhani Kahri, Marja-Riitta Taskinen
Nutrients
|
August 25, 2019
Dietary Fructose and the Metabolic Syndrome
Marja-Riitta Taskinen, Chris J Packard, Jan Borén
Frontiers in Endocrinology
|
June 2, 2020
Causes and Consequences of Hypertriglyceridemia
Chris J Packard, Jan Boren, Marja-Riitta Taskinen
Annual Review of Nutrition
|
April 18, 2024
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja-Riitta Taskinen, Chris J Packard
Frontiers in Endocrinology
|
August 28, 2020
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Borén, Chris J Packard, Marja-Riitta Taskinen
Page
of 23